BMHS Stock Overview
Provides health care services in Indonesia. More details
Snowflake Score | |
---|---|
Valuation | 3/6 |
Future Growth | 1/6 |
Past Performance | 1/6 |
Financial Health | 4/6 |
Dividends | 0/6 |
PT Bundamedik Tbk Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | Rp268.00 |
52 Week High | Rp396.00 |
52 Week Low | Rp230.00 |
Beta | -0.23 |
11 Month Change | -6.94% |
3 Month Change | -10.07% |
1 Year Change | -29.10% |
33 Year Change | -68.66% |
5 Year Change | n/a |
Change since IPO | -36.79% |
Recent News & Updates
Recent updates
Shareholder Returns
BMHS | ID Healthcare | ID Market | |
---|---|---|---|
7D | -3.6% | -2.2% | -0.1% |
1Y | -29.1% | 23.2% | 7.6% |
Return vs Industry: BMHS underperformed the ID Healthcare industry which returned 23.2% over the past year.
Return vs Market: BMHS underperformed the ID Market which returned 7.6% over the past year.
Price Volatility
BMHS volatility | |
---|---|
BMHS Average Weekly Movement | 5.1% |
Healthcare Industry Average Movement | 5.4% |
Market Average Movement | 5.5% |
10% most volatile stocks in ID Market | 12.6% |
10% least volatile stocks in ID Market | 2.3% |
Stable Share Price: BMHS has not had significant price volatility in the past 3 months compared to the ID market.
Volatility Over Time: BMHS's weekly volatility (5%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1973 | 1,434 | Agus Darjono | www.bmhs.co.id |
PT Bundamedik Tbk provides health care services in Indonesia. The company also engages in the wholesale and distribution of drugs, pharmaceuticals, and medical equipment; private hospital and healthcare support service activities; provision of ambulance services; private health education; consultant for reproductive technology services management; management consultant of physiotherapy service; and hotel, medical tourism, and management consulting businesses. It operates maternal and child hospitals, general hospitals, clinics, IVF clinics, and diagnostic laboratories.
PT Bundamedik Tbk Fundamentals Summary
BMHS fundamental statistics | |
---|---|
Market cap | Rp2.31t |
Earnings (TTM) | Rp13.05b |
Revenue (TTM) | Rp1.55t |
176.7x
P/E Ratio1.5x
P/S RatioIs BMHS overvalued?
See Fair Value and valuation analysisEarnings & Revenue
BMHS income statement (TTM) | |
---|---|
Revenue | Rp1.55t |
Cost of Revenue | Rp838.29b |
Gross Profit | Rp708.05b |
Other Expenses | Rp695.00b |
Earnings | Rp13.05b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | 1.52 |
Gross Margin | 45.79% |
Net Profit Margin | 0.84% |
Debt/Equity Ratio | 66.0% |
How did BMHS perform over the long term?
See historical performance and comparison